Dual antiplatelet therapy with aspirin and clopidogrel is effective in limiting adverse coronary thromboischemic events in most patients undergoing coronary stenting. However, platelet reactivity to clopidogrel is variable and stent thrombosis can occur suddenly and unexpectedly in up to 3% of patients. Is responsiveness to clopidogrel an indicator of risk of post-treatment thromboischemic events?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets
Nature Communications Open Access 07 June 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Spaulding, C. et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N. Engl. J. Med. 355, 1093–1104 (2006).
Neumann, F. J. et al. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting. J. Am. Coll. Cardiol. 27, 15–21 (1996).
Müller, I. et al. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb. Haemost. 89, 783–787 (2003).
Geisler, T. et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur. Heart J. 27, 2420–2425 (2006).
Snoep, J. D. et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am. Heart J. 154, 221–231 (2007).
Sibbing, D. et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J. Am. Coll. Cardiol. 53, 849–856 (2009).
Gurbel, P. A. et al. Clopidogrel effect on platelet reactivity in patients with stent thrombosis. J. Am. Coll. Cardiol. 46, 1827–1832 (2005).
Buonamici, P. et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J. Am. Coll. Cardiol. 49, 2312–2317 (2007).
Hulot, J.-S. & Fuster, V. Personalized medicine for clopidogrel resistance? Nat. Rev. Cardiol. 6, 334–336 (2009).
Geisler, T. et al. The residual platelet aggregation after deployment of intracoronary stent (PREDICT) score. J. Thromb. Haemost. 6, 54–61 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gawaz, M., Geisler, T. Platelet activity: an obstacle for successful PCI. Nat Rev Cardiol 6, 391–392 (2009). https://doi.org/10.1038/nrcardio.2009.76
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2009.76
This article is cited by
-
The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets
Nature Communications (2021)